News & Blog

HomeNews & Blog
News & Blog2022-03-08T10:06:59-05:00
May26, 2021

LaunchWorks and Canadienzyme Collaboration Results in New Product for Diagnostic Testing

By |May 26th, 2021|Categories: News|0 Comments

LaunchWorks and Canadienzyme, a biotech spin-off company by two McGill University scientists, announced their collaboration to produce a new RT-qPCR Master Mix.

Canadienzyme stepped in to help Canada’s national efforts due to a shortage of tests amid the Coronavirus pandemic.  In doing so, they created a made-in-Canada RT-qPCR testing reagent that works as well as international versions on patient samples. This new Master Mix provides a domestic supply in Canada and increases available inventory in the U.S.

“Prior to COVID-19, there were no made-in-Canada RT-PCR testing solutions. Seeing the need; we stepped in to make these tests domestically so Canadians could be tested reliably on a broad scale,” said Dr. Martin Schmeing, CEO of Canadienzyme. “These tests are designed not just for the current pandemic, but will also equip Canada to respond quickly to other future challenges to the health of Canadians. We anticipate that the Master Mix can be applied for use in most, if not all, clinical diagnostic PCR testing applications.”

“By leveraging our commercial expertise with Canadienzyme’s scientific innovation, we were able to launch the Master Mix in record speed and increase access to a much-needed product,” says Celine Barakat, General Manager of LaunchWorks. “By collaborating directly with inventors and scientists, we’ve proven that we can bring innovative life science solutions to market quickly and efficiently.”

The new RT-qPCR Master Mix developed by Canadienzyme is now available through LaunchWorks in the US and Canada. The two companies will continue to work together to explore other diagnostic products and to bolster Canadian innovation and manufacturing in life sciences.

May06, 2021

LaunchWorks Scales up its Diagnostic Test Kit Manufacturing Capabilities

By |May 6th, 2021|Categories: News|0 Comments

LaunchWorks has increased its filling capacity for the production of diagnostic test kits with the addition of new automation equipment at its Beverly, MA and Anjou, Canada facilities.

The expansion is part of LaunchWorks response to help meet the world’s public health needs in disease diagnosis and the fight against COVID-19. With the addition of the new filling automation equipment, LaunchWorks has the functionality and capacity to produce up to 500,000 microtubes or transport media tubes per week. The new automation also improves the quality process by increasing the reproducibility of vial filling.

“Our new suite of filling and capping machines will be easily redeployed for different formulations, allowing us to reduce the cost of manufacturing for customers,” says Celine Barakat, General Manager of LaunchWorks. “This increased capacity reinforces our commitment to support the world’s changing needs during the pandemic, and, beyond that, the growing molecular diagnostics market.”

Originally formed within Enzymatics in 2009 and now in two locations (Beverly, MA and Anjou, Canada), LaunchWorks has evolved over the past 12 years to become an ISO 13485 certified company that is FDA Registered. Integreon Global acquired LaunchWorks in 2017, and has since worked to add new service offerings, including embarking on a filing automation program designed to help its customers be more competitive. A significant portion of the company’s recent efforts has revolved around the response to the COVID-19 crisis.

Please contact us for more information or to get started on a project.

Aug21, 2020

LexaGene Holdings Hires Contract Manufacturer LaunchWorks to Support MiQLab Launch

By |August 21st, 2020|Categories: News|0 Comments

LexaGene Holdings Inc announced another milestone in its journey to commercially launch flagship analyzer product MiQLab before the end of September – the hiring of LaunchWorks as its contract manufacturer.

LaunchWorks is an FDA registered, ISO 13485 certified, cGMP compliant group specializing in manufacturing consumables for life science firms, LexaGene said.

It will manufacture the assay panels and buffer sets used in LexaGene’s fully automated MiQLab system.

“LaunchWorks can currently manufacture enough products to easily support our commercial launch and have the facilities to scale their production to meet any demands that we require. I am very impressed by their facilities, high caliber staff, and their ability to scale their operations to meet our needs as we grow,” Dr Jack Regan, LexaGene’s CEO and founder, told investors in a statement.

MiQLab is a fully automated genetic analyzer designed to deliver reference-quality data at the point-of-need and can return results in about one hour. LexaGene says the technology can be used in multiple billion-dollar markets, including human and veterinary diagnostics as well as food safety testing.

“This is an extremely exciting time for LexaGene. Our initial hires in sales are working out exceedingly well and we are in the home stretch for manufacturing and qualification. By the end of next month, we expect to begin selling and fulfilling delivery of our first units, which will be a huge milestone for the company,” added Daryl Rebeck, LexaGene’s president and co-founder.

Aug03, 2020

Scaling Up COVID-19 Test Kit Manufacturing With Automation

By |August 3rd, 2020|Categories: News|0 Comments

Like many businesses, LaunchWorks was thrown for a loop when the COVID-19 pandemic hit, but not in the same way as some other manufacturers. The company was already on a strong growth trajectory for 2020, but when shelter-in-place mandates were announced, access to doctors’ offices limited the activity of most of the existing customer base. The company was able to harness its strengths to quickly pivot by promoting and expanding COVID-19 test kit manufacturing capabilities. As a result, LaunchWorks anticipates tripling its size this year.  Automation is a key factor in scaling up to serve clients.

Expanding that quickly to help meet the country’s public health needs is not a simple task. The company focused on a combination of long-term industry supplier relationships, innovative thinking and automation solutions. LaunchWorks already utilized automation, but adding new functionality and additional capacity for the COVID-19 efforts helped move from producing 75,000 transport media tubes a week to an anticipated 1 million per week. (more…)

Jun12, 2020

A message from our CEO

By |June 12th, 2020|Categories: News|0 Comments

The lack of humanity reflected in the death of George Floyd, the senseless deaths of so many others in our minority communities and the Black Lives Matter response have caused me to reflect on my limitations in implicitly supporting a status quo that has lead our communities to where we are today. (more…)